-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E3LUZDvMMMt4na+NwLkFSL6QyOAl+UTfjvaTC2+5dslJd4TtKPa1FSGOTd+IetAV r2JVnl40Pg0vRxi9Rdsu+g== 0001047469-03-022940.txt : 20030701 0001047469-03-022940.hdr.sgml : 20030701 20030630174606 ACCESSION NUMBER: 0001047469-03-022940 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030630 ITEM INFORMATION: Other events FILED AS OF DATE: 20030701 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 03765787 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 8-K 1 a2113629z8-k.htm 8-K
QuickLinks -- Click here to rapidly navigate through this document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549


FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED):
June 30, 2003

GENZYME CORPORATION
(Exact name of registrant as specified in its charter)

Massachusetts
(State or other jurisdiction of
incorporation or organization)		   0-14680
(Commission
file number)		   06-1047163
(IRS employer
identification number)


One Kendall Square, Cambridge, Massachusetts 02139
(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code:
 (617) 252-7500

Item 5. Other Events.

        At 11:59 p.m. on June 30, 2003, Genzyme completed a previously announced exchange of (1) each share of its Genzyme Biosurgery Division common stock (Nasdaq: GZBX) ("GZBX Stock") for 0.04914 of a share of Genzyme General Division Common Stock (Nasdaq: GENZ) ("GENZ Stock") and (2) each share of its Genzyme Molecular Oncology Division common stock (Nasdaq: GZMO) ("GZMO Stock") for 0.05653 of a share of GENZ Stock. A total of 2,959,230 shares of GENZ Stock were issued in the exchange—(1,999,461 on account of the GZBX Stock and 959,769 on account of the GZMO Stock.


SIGNATURE

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    GENZYME CORPORATION

Dated: July 1, 2003
 
By:
/s/  MICHAEL S. WYZGA      
Michael S. Wyzga
Executive Vice President, Finance;
Chief Financial Officer; and
Chief Accounting Officer


QuickLinks

SIGNATURE
 -----END PRIVACY-ENHANCED MESSAGE-----